ReWalk Robotics Ltd (LFWD): Debts to Book Capitalization

Brandmark of ReWalk Robotics (LFWD)

The ReWalk Robotics Ltd. (LFWD) debt-to-market cap chart illustrates the dynamics of the debt load, where the parameter value equals 0.97. Management transparency and leadership expertise in rehabilitation stabilize the asset structure. The use of external production sites and logistics partners optimizes operating expenses. Patent protection for exoskeletons and stringent FDA regulatory barriers ensure business resilience.

LFWD - Lifeward Ltd. Debts to Net Assets over the range 02/21/2024 - 10/27/2026
Original product of ReWalk Robotics

ReWalk Robotics Ltd. (LFWD) maintains its leadership in the rehabilitation exoskeleton niche through patent protection and US insurance codes. This metric compares total debt to the book value of equity to assess financial stability. It is critical for investors to understand the extent to which the debt load outweighs the business's own resources during periods of volatility. Analyzing the debt-to-capitalization ratio on GURU.Markets allows for the rapid identification of default risks. The price action on this chart determines the company's ability to invest in development amidst market turmoil.

Competitors of ReWalk Robotics Ltd.

BSX: Debts to Book Capitalization|Debts to Book Value edwards.com EW|RMD: Debts to Book Capitalization|PODD - Debt to Book Value|Zimmer Biomet - Debts to Book Capitalization|CooperSurgical (COO) - Debts to Net Assets|ALGN (Align Technology, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization GMED|Debt to Book Capitalization Ratio TransMedics Organ Care System (TMDX)|Debt to Book Capitalization Ratio Alphatec Holdings (ATEC)|Debts to Book Capitalization AORT|ENOV - Debts to Net Assets|Debt to Book Value Integra LifeSciences|ESTA - Debts to Book Capitalization Ratio|Debts to Book Capitalization BBNX|IRADIMED Corp (IRMD) - Debts to Book Value|Debts to Book Capitalization Embecta Inc. (EMBC)|Debt to Book Value Ratio Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Debt to Book Value|Debt to Net Assets Ratio SIBN (si-bone.com)|Orthofix - Debt to Book Capitalization Ratio|Debt to Book Value Bioventus Inc BVS|KIDS (OrthoPediatrics Inc.) - Debts to Book Capitalization|TMCI - Debts to Book Value|Debts to Book Capitalization Strata Critical Medical Inc|carlsmed.com (CARL) - Debt to Book Value Ratio|RXST: Debts to Book Capitalization|Debts to Net Assets ClearPoint|Debts to Book Capitalization STXS (Stereotaxis Corp)|Debt to Book Value Neuronetics, Inc (STIM)|Debts to Book Capitalization SGHT (Sight Sciences, Inc.)|Orchestra BioMed Inc. - Debts to Book Capitalization|ANIK - Debt to Book Capitalization Ratio|InspireMD Inc (NSPR) - Debt to Book Capitalization Ratio|Debt to Book Value zhjmedical.com ZJYL|Vivani Medical (VANI) - Debt to Net Assets Ratio|Debts to Book Capitalization XTNT (Xtant Medical Holdings, Inc.)|Debts to Book Value NMTC|MODD: Debt to Book Capitalization Ratio|Debt to Net Assets Myomo Inc. MYO|Debt to Book Value COCH (Envoy Medical, Inc)|Debts to Book Capitalization Vivos Therapeutics Inc VVOS|Debts to Book Capitalization NVNO (enVVeno Medical)|SINT: Debts to Net Assets|Debt to Book Capitalization Ratio Tenon Medical (TNON)|AMIX (Autonomix Medical) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio IVF|Debt to Book Value Bone Biologics Inc|Axonics, Inc. - Debts to Book Capitalization|Debts to Book Value BIOL (biolase.com)|DYNT - Debt to Book Capitalization Ratio|FNA - Debt to Book Value Ratio|Debt to Book Value INVO Bio INVO